Picture of SI-BONE logo

SIBN — SI-BONE News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

SI-BONE Inc expected to post a loss of 39 cents a share - Earnings Preview

* SI-BONE Inc  SIBN.OQ   SIBN.O  is expected to show a rise in
quarterly revenue when it reports results on August 2. 
* The Santa Clara, California-based company is expected to
report   a 56.3% increase in revenue to $21.957 million from
$14.05 million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for SI-BONE Inc is for a
loss of 39 cents per share. For the same quarter last year, the
company reported a loss of 44 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for SI-BONE Inc is
$41.5​, about 27.8% above​ its last closing price of $29.95. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.40       -0.40      -0.37     Beat    7.2
 Dec. 31 2020  -0.27       -0.30      -0.28     Beat    7.3
 Sep. 30 2020  -0.38       -0.39      -0.33     Beat    14.7​
 Jun. 30 2020  -0.63       -0.64      -0.44     Beat    31.2
 Mar.          -0.38​      -0.38      -0.47     Missed  -22.5​
 31​ 2020​                                              
 Dec. 31 2019  -0.35       -0.35      -0.36     Missed  -3.3​
 Sep. 30 2019  -0.37       -0.37      -0.46     Missed  -23.5
 Jun. 30 2019  -0.38       -0.35      -0.35     Met     -0.7
 This summary was machine generated July 30 at 21:18 GMT.  All
figures in US dollars unless otherwise stated

Recent news on SI-BONE

See all news